Sarion Bowers, Policy Lead at the Sanger Institute, reflects on how Brexit will affect science.
The idea that we should benefit from scientific advancement is something we may never have thought of as human right, yet the Universal Declaration of Human Rights firmly makes the case that it is everyone's right, regardless of education, wealth or background, explains Sarion Bowers
Now is the time for scientists to strike a deal everyone that benefits society as well as research, argue Anna Middleton, Vivienne Parry and Julian Borra
03.08.17 This week the American Society of Human Genetics issued a policy on the application of germline editing – the ability to alter the genetic makeup of early stage embryos. Anna Middleton, one of the contributors to the statement, explains the policy's position
Chief Medical Officer’s annual report 2016: Generation Genome highlights the potential for pathogen genomics in patient diagnosis and infection control
04.07.17 The UK Chief Medical Officer's Report has highlighted the vital role genetics and genomics will play in UK NHS healthcare and medicine. Professor Sharon Peacock helped write the report's chapter on Infectious disease.
25.05.16 Personalised medicine is the promise of genomic research, but to make it a reality will take a community of researchers, clinicians, healthcare workers, policy makers and patients, Sarion Bowers explains
Editing the genome is a grand endeavour. Discussions on the aims and regulation of genome editing need to reflect the opinion of both scientists and the public. Sarion Bowers explains.